CoverageForm 410-K10-Q8-K13D13G13F

PANA · Panacea Acquisition Corp. II - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Income Statement

Line itemFY 2022FY 2021
Revenue--
Cost of Revenue--
Gross Profit--
R&D--
SG&A--
Total Operating Expenses$974.9K$745.9K
D&A--
Operating Income($974.9K)($745.9K)
Interest Expense--
Income Tax--
Net Income$1.43M($736.3K)
EPS - Basic--
EPS - Diluted--

Balance Sheet

Line itemFY 2022FY 2021
Cash & Equivalents$70.0K$353.1K
Accounts Receivable--
Inventory--
Accounts Payable--
Current Assets$207.9K$1.05M
Total Assets$175.12M$173.55M
Current Liabilities$433.7K$296.2K
Long-term Debt--
Total Liabilities$6.47M$6.33M
Stockholders' Equity($6.26M)($5.28M)
Retained Earnings($6.26M)($5.28M)

Cash Flow

Line itemFY 2022FY 2021
Operating Cash Flow($283.1K)($1.23M)
Investing Cash Flow-($172.50M)
Financing Cash Flow-$174.08M
CapEx--
Free Cash Flow--

Ratios

MetricFY 2022FY 2021
Profitability
Gross margin--
Operating margin--
EBITDA margin--
Net margin--
Free cash flow margin--
FCF / Net income--
R&D / Revenue--
SG&A / Revenue--
Effective tax rate--
Return on assets0.8%-0.4%
Return on equity-22.8%13.9%
Return on invested capital--
Liquidity
Current ratio0.483.53
Quick ratio0.483.53
Cash ratio0.161.19
Leverage
Debt / Equity--
Debt / Assets--
Debt / EBITDA--
Interest coverage--
Equity multiplier-27.96-32.88
Liabilities / Assets0.040.04
Efficiency
Asset turnover--
Inventory turnover--
Days sales outstanding--
Days inventory outstanding--
Days payable outstanding--
Cash conversion cycle--
Valuation
P / E--
P / B--
P / S--
EV / EBITDA--
Growth
Revenue growth (YoY)--
Revenue CAGR (3y)--
Revenue CAGR (5y)--
Gross profit growth (YoY)--
Operating income growth (YoY)-30.7%-
Net income growth (YoY)--
EPS growth (YoY)--
EPS CAGR (3y)--
EPS CAGR (5y)--
FCF growth (YoY)--
FCF CAGR (5y)--
Book value growth (YoY)-18.7%-

Stability scores

Piotroski F-score

FY 2022 · 9-point quality

2/9
Weak
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • -Long-term debt decreased
  • Current ratio improved
  • -No share dilution
  • -Gross margin improved
  • -Asset turnover improved

Peer comparison

Same SIC group: Blank Checks

CompanyRevenue (last FY)Net marginROE
ISPO---
INV$2.06M-14266.4%-143.6%
IEA$2.08B-4.0%-224.7%
TWOA---42.8%
BOCN---

Comparing Panacea Acquisition Corp. II against the 5 most active filers in the same SIC group.